Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc > New Article

<< Previous

Bullboard Posts

Next >>

Comment by Winnipeg40on Jan 18, 2023 10:09pm

293 Views

Post# 35232197

RE:RE:RE:RE:RE:New Article

Great deal...take a bunch of cash out of the Company in related party transactions, an inflated CEO salary for working part-time and 60% of time on multiple other Companies, private and public while in Florida a good part of the year, charge rent for more office space than double what is needed and then use the funds to buy more shares. Great gig if you have no morals

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023